Zura Bio Ltd
ZURA$435M
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaLA JOLLA
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
3
Next Catalyst
Sep 15, 2026
26wMarket Overview
Stock performance and key metrics
ZURA News
Catalyst Timeline
3 upcoming, 1 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Tibulizumab Dose A | Phase 2 | Hidradenitis Suppurativa (HS) | - | - |
Tibulizumab | Phase 2 | Systemic Sclerosis (SSc) | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply